US EditionNSCEB Announces Biotech Across America Roadshow, Makes First Stop in North Carolina
- The Biotech Across America Road Tour started in North Carolina, featuring the commission responsible for advising Congress on biotechnology’s role in national security and industry growth.
- This event follows $11 billion in announced biotech investments over the last 18 months, driven by expanding manufacturing demand and strategic federal recommendations.
- Fujifilm has invested $8 billion globally in life sciences manufacturing, including $4 billion in North Carolina, while Amgen initiated an expansion in January to meet the rising demand.
- Dr. Michelle Rozo stated, "We recognize the growth potential in biotech," emphasizing that workforce training and university partnerships will support companies like Genentech and Amgen.
- Leaders agree that expanding workforce programs and treating biotech as a national security priority will strengthen North Carolina's biotech sector and manufacturing capacity.
Insights by Ground AI
Does this summary seem wrong?
46 Articles
46 Articles
All
Left
6
Center
14
Right
6
Biotech boom in North Carolina tied to national security, say industry leaders
Biotechnology is a growing industry in North Carolina. Leaders from the National Security Commission on Emerging Biotechnology (NSCEB) and the North Carolina Biotechnology Center said this week that expanding workforce training and strengthening partnerships with local universities are key steps to support the sector, which they noted has national security implications “We recognize the growth potential in biotech,” Dr. Michelle Rozo, vice chair…
Coverage Details
Total News Sources46
Leaning Left6Leaning Right6Center14Last UpdatedBias Distribution54% Center
Bias Distribution
- 54% of the sources are Center
54% Center
L 23%
C 54%
R 23%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
